| Angiosarcoma studied in …STUDIED_INderived53 of 53show fewer |
|---|
| → studied in | NCT06440005Phase 1 · recruiting A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339738Phase 2 · active not recruiting Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06898970Phase 2 · recruiting Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331250Phase 2 · completed Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05026736Phase 2 · terminated Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study · condition mapped CURATED_BROADER · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069378Phase 2 · active not recruiting A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04668300Phase 2 · active not recruiting Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma · condition mapped CURATED_BROADER · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042379Phase 2 · recruiting I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860272Phase 1 · active not recruiting Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303497Phase 2 · completed Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06715579recruiting Cardiac Angiosarcoma International Registry · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Cardiac Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055220NA · recruiting Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799612Phase 1 · withdrawn Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849986Phase 2 · recruiting IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375941recruiting Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02625389Phase 4 · completed A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06535997completed Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04518124Phase 2 · completed Propranolol in Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05961761Phase 2 · recruiting Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293289NA · completed Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03921073Phase 2 · terminated Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05515068not yet recruiting Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Bone Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01462630Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048722Phase 2 · completed Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02212015Phase 2 · terminated Evaluation of Votrient in Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04607200Phase 2 · withdrawn AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02979899Phase 3 · completed Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma · condition mapped CURATED_BROADER · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Childhood Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03512834Phase 2 · unknown Paclitaxel-Avelumab for Angiosarcoma · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055028Phase 2 · terminated Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025438completed Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation · condition mapped ALIAS · 53 trials mapped (20 active) | — | — | Liver Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786889NA · unknown Identification, Molecular Epidemiology Angiosarcoma of the Liver France · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567046completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Childhood Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02732678Phase 1/Phase 2 · unknown Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887809Phase 2 · completed Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01623869Phase 2 · completed Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (20 active) | — | — | Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |